Before joining Augmedics, Tim Murawski served as president and CEO for a medical device company that manufactures devices for managing diabetes. Earlier, he spent nine years as an executive director for a medical device company in Japan. Augmedics is excited to be expanding its efforts in a technology where there is a large need for support. Tim’s leadership and insight will be crucial to our continued success.
Tim has visibly supported Augmedics and its Mazor robot at several events. Tim has visibly supported Augmedics and its Mazor robot at several events. Prior to joining Augmedics, he served as the president and chief commercial officer for the Mazor Robotics company. “Augmedics is very fortunate to have Tim Murawski as an advisor, and we are looking forward to working with him,” said Craig Sanocki, President, and CEO of Augmedics.
Tim Murawski has a long track record of innovating market entry and implementing profitable strategies. He worked with Apax Partners for more than ten years, where he led and supported many early-stage investments and successful exits. Besides acting as operations director at RHK Capital, he spent two years as a partner at Goldhill Capital, a private equity firm.
Tim was also a management consultant at Deloitte Consulting for three years, where he advised Fortune 500 companies in new product and process development and global expansion strategies. He was a part of Deloitte’s Global Reimbursement Services and the Healthcare Technology Practice. Led by Tim Murawski, Augmedics is the developer of the augmented reality (AR) surgical robot, MRX. Augmedics partners with hospitals and health systems across the globe to deploy MRX for surgical planning, navigation, and guidance.